Navigation Links
.decimal, Inc. Gains 510k Clearance from the FDA to Market its p.d(TM) Software for Bolus Electron Conformal Therapy in the United States
Date:5/11/2009

SANFORD, Fla., May 11 /PRNewswire/ -- .decimal, leading manufacturer of patient-specific medical devices, gains 510k clearance to release the software necessary for the delivery of Bolus Electron Conformal Therapy (Bolus ECT(TM)), an advanced form of patient-specific electron therapy. Treating with bolus ECT will be available to users of all three of the major treatment planning systems: CMS XiO(TM), Varian Eclipse(TM) and Philips Pinnacle3(TM).

(Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO )

510k clearance to market the device makes it possible for cancer treatment centers in the United States to begin ordering, installing and using .decimal's propriety software, p.d, for bolus ECT. "We are now actively marketing bolus electron conformal therapy, and the response from institutions across the United States has been overwhelming as they begin to see the value to their patients through this innovative technology," says Mark Mills, Senior Vice President of Sales and Marketing at .decimal.

.decimal is the sole manufacturer of the bolus, as well as the sole software provider for bolus ECT planning.

Richard Sweat, President and CEO of the company explains, "The commercial availability of bolus electron conformal therapy is another example of our commitment to providing our customers with innovative treatment solutions and their patients with the best individualized electron treatment available in the world."

Bolus ECT can create favorable dose distributions for certain tumors of the chest wall, breast or head and neck, when a tumor volume has spread out near the patient surface and rendered other treatment problematic for a variety of reasons. Bolus ECT was first used at the University of Texas M.D. Anderson Cancer Center over ten years ago, but did not become commercially available until this software release.

"With this product we are enabling the 80% of radiation oncology facilities in the United States treating with electrons the opportunity to enhance their current electron delivery capabilities through our unique pay-as-you-go, Internet-based manufacturing business model," says Sweat.

.decimal is a medical device manufacturer of patient-specific devices, including missing tissue compensators, modulators for advanced IMRT delivery, bolus compensators for bolus electron conformal therapy, as well as apertures and range compensators used in proton therapy. The company has been providing radiation therapy products for over twenty years. For more information concerning .decimal, please see its Web site at www.dotdecimal.com.


'/>"/>
SOURCE .decimal, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. iCardiac's Highly Automated QT(sm) Technology Cross-Validated Against Results from Five Leading ECG Core Laboratories
2. Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
3. Grey Ribbon Crusade(TM) Promotes National Unification in the Fight Against Brain Tumors
4. Obama Administration Rules Against Californias Proposed Wage Cuts to Homecare Workers
5. NABP Position Paper Calls for Action Against Proliferation of Rogue Internet Drug Outlets
6. Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture
7. Research opens up new horizons to the design of customized medicines against breast cancer
8. Viroblock SA Reports a 99% Boost of Efficacy of Facemasks Against H5N1
9. Oust(R) Surface Disinfectant & Air Sanitizer Effective Against H1N1
10. Federal District Judge Dismisses Antitrust Lawsuit Against Batesville Casket Company
11. Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... ... American Osteopathic Association’s (AOA) Match Program Tuesday, February 9, taking one of the ... into osteopathic graduate medical education positions across the country. Of the 103 student-doctors ...
(Date:2/11/2016)... ... 2016 , ... Image One USA veteran franchise owner Maria Bogacki ... buildings of Nashville that will benefit. , “I’ve enjoyed being a part of the ... was no question that I would bring my business with me,” Bogacki said. “The ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... and women’s health, is pleased to announce the promotions of Allison Kelly to ... team, Steve Catone to executive vice president of North American capital sales, and ...
(Date:2/11/2016)... ISLAND, Australia (PRWEB) , ... February 11, 2016 ... ... full potential ?" motivational speaker, trainer and author Ray Clarke poses a question ... personal fulfillment . In his book, "Being in the Being" (published by ...
(Date:2/11/2016)... ... February 11, 2016 , ... AccuVein ... resource, Infusion Therapy Standards of Practice, to include vascular visualization as a standard ... estimated 85% share of the market, facilitates adherence to this standard with its ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Potrero Medical, Inc., the developer of the Accuryn™ ... of George M. Rapier, III , MD, to its ... , WellMed is one of the nation,s largest physician owned ... in Texas and Florida ... own internal medicine practice, he has been instrumental to the ...
(Date:2/11/2016)... Feb. 11, 2016 AAIPharma Services Corp./Cambridge ... custom manufacturing and development services for the pharmaceutical ... capabilities and capacity in its Charleston, ... has driven several recent investments. ... one filling line with small-scale lyophilization. The site ...
(Date:2/11/2016)... , Feb. 11, 2016 Wearable posture tracker, ALEX , has taken Kickstarter by ... and just seven days left to go, ALEX is said to be delivered to backers starting May ... ... ... Created by ...
Breaking Medicine Technology: